Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

Ferreiro-Pantín, M. ; Anido-Herranz, U. ; Betancor, Y.Z. ; Cebey-López, V. ; León-Mateos, L. ; García-González, J. ; García-Acuña, S.M. ; Fernández-Díaz, N. ; Tubio, J.M.C. ; López-López, R. ; Ruiz-Bañobre, J.

ESMO open, 2023-08, Vol.8 (4), p.101611-101611, Article 101611 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível